In addition to these well-studied common and rare EGFR mutations, EGFR variants of uncertain significance (VUS) were observed in lung cancer patients, but the clinical relevance and TKI sensitivity of these VUSs are largely unknown [16, 17]. The gene discussed is EGFR; the disease is lung cancer.